Advisor Group Holdings, Inc. Biora Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 10, 2022	SELL	$0.56 - $1.22 $280 - $610	-500 Reduced 2.83%	17,186 $12,000
Q1 2022 May 04, 2022	BUY	$1.11 - $2.25 $555 - $1,125	500 Added 2.91%	17,686 $20,000
Q2 2021 Aug 02, 2021	SELL	$2.11 - $4.93 $841 - $1,967	-399 Reduced 2.27%	17,186 $61,000
Q1 2021 May 13, 2021	BUY	$3.91 - $7.31 $67,697 - $126,565	17,314 Added 6388.93%	17,585 $84,000
Q4 2020 Feb 10, 2021	SELL	$3.27 - $9.48 $25,833 - $74,892	-7,900 Reduced 96.68%	271 $1,000
Q3 2020 Nov 12, 2020	BUY	$7.71 - $10.79 $61,294 - $85,780	7,950 Added 3597.29%	8,171 $74,000
Q2 2020 Aug 14, 2020	BUY	$9.0 - $13.12 $1,989 - $2,899	221 New	221 $2,000

Others Institutions Holding BIOR

# of Institutions

2

Shares Held

890

Call Options Held

0

Put Options Held

0

About BIORA THERAPEUTICS, INC.

Ticker BIOR
Exchange NASDAQ
Shares Outstandng 186,623,605
Market Cap $299M
Description
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...

More about BIOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.